Provide virtual primary care that augments clinicians with AI-assisted workflows and chat-based medical support.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Curai is an AI-powered virtual primary care platform that reimagines healthcare by automating routine clinical workflows and enabling seamless, chat-first medical support. It augments clinician capacity with intelligent triage, follow-ups, and diagnostics, turning virtual care into efficient, accessible, and high-quality clinical experiences.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Curai Management Team
Investors
General Catalyst
Khosla Ventures
Morningside Venture Investments, Ltd.
Curai Valuations & Financials
View real-time NPM data on Curai stock including daily Curai stock price estimates, valuation history, and historical share price information. Access Curai financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Curai pricing across six independent market signals. Looking for private company due diligence data sources on Curai? Get in touch to learn more.
Similar Companies
like Curai
KromaTiD
Healthcare & Life Sciences
Delivering single-cell cytogenetic clarity for gene editing and cell therapies with high-confidence genome integrity analysis.
Firefly Bio
Healthcare & Life Sciences
Create cancer therapies that use Degrader Antibody Conjugates to precisely deliver payloads and degrade target proteins while minimizing collateral damage.
Bennie
Healthcare & Life Sciences
Digital platform streamlines employee benefits management, offering health plans and insurance solutions to optimize workplace benefits delivery.
Particella
Healthcare & Life Sciences
Creates technology that delivers nucleic acid medicines orally for targeted treatment in the gastrointestinal tract.
VenoStent
Healthcare & Life Sciences
Develops bioresorbable polymer wraps to prevent vascular access surgery failures in hemodialysis patients, addressing a critical healthcare challenge.
Qnovia
Healthcare & Life Sciences
Provides clinical imaging software that standardizes workflows and reporting to improve diagnostic productivity and consistency.
Synedgen
Healthcare & Life Sciences
Modulate immunity that focuses on mucosal surfaces to repair damage and suppress inflammation via orally-delivered, glycopolymer-derived therapeutics.
Arbital Health
Healthcare & Life Sciences
Streamlines value-based care contracting by automating analytics, performance tracking, and adjudication with AI-powered actuarial precision.
Kenai Therapeutics
Healthcare & Life Sciences
Biotechnology company developing off-the-shelf neuron replacement therapies using iPSC technology to treat neurological disorders.
FAQ
We have answers
Curai stock does not trade on public stock exchanges. Curai stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Curai stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Curai Stock does not trade on public stock exchanges. In order to sell Curai shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Curai does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Curai share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Curai stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Curai stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Curai stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Curai is a private company and has not had an IPO. There is currently no Curai IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Curai IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
